210 related articles for article (PubMed ID: 9748560)
1. Clinical applications of anticancer drugs targeted to topoisomerase II.
Hande KR
Biochim Biophys Acta; 1998 Oct; 1400(1-3):173-84. PubMed ID: 9748560
[TBL] [Abstract][Full Text] [Related]
2. Toxicity of the topoisomerase II inhibitors.
Seiter K
Expert Opin Drug Saf; 2005 Mar; 4(2):219-34. PubMed ID: 15794715
[TBL] [Abstract][Full Text] [Related]
3. Camptothecin and podophyllotoxin derivatives: inhibitors of topoisomerase I and II - mechanisms of action, pharmacokinetics and toxicity profile.
Hartmann JT; Lipp HP
Drug Saf; 2006; 29(3):209-30. PubMed ID: 16524321
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of NF-kappaB activation and function by topoisomerase II inhibitors.
Campbell KJ; O'Shea JM; Perkins ND
BMC Cancer; 2006 Apr; 6():101. PubMed ID: 16630341
[TBL] [Abstract][Full Text] [Related]
5. Etoposide: four decades of development of a topoisomerase II inhibitor.
Hande KR
Eur J Cancer; 1998 Sep; 34(10):1514-21. PubMed ID: 9893622
[TBL] [Abstract][Full Text] [Related]
6. Topoisomerase inhibitors. A review of their therapeutic potential in cancer.
Sinha BK
Drugs; 1995 Jan; 49(1):11-9. PubMed ID: 7705211
[TBL] [Abstract][Full Text] [Related]
7. Mitoxantrone, More than Just Another Topoisomerase II Poison.
Evison BJ; Sleebs BE; Watson KG; Phillips DR; Cutts SM
Med Res Rev; 2016 Mar; 36(2):248-99. PubMed ID: 26286294
[TBL] [Abstract][Full Text] [Related]
8. DNA topoisomerase II inhibitors.
IARC Monogr Eval Carcinog Risks Hum; 2000; 76():175-344. PubMed ID: 11000976
[No Abstract] [Full Text] [Related]
9. DNA topoisomerases and their poisoning by anticancer and antibacterial drugs.
Pommier Y; Leo E; Zhang H; Marchand C
Chem Biol; 2010 May; 17(5):421-33. PubMed ID: 20534341
[TBL] [Abstract][Full Text] [Related]
10. Clinical development of topoisomerase-interactive drugs.
Muggia FM; Burris HA
Adv Pharmacol; 1994; 29B():1-31. PubMed ID: 8996599
[No Abstract] [Full Text] [Related]
11. Discovery of podophyllotoxins.
Imbert TF
Biochimie; 1998 Mar; 80(3):207-22. PubMed ID: 9615861
[TBL] [Abstract][Full Text] [Related]
12. Biochemical modulation of cytotoxic drugs by cytokines: molecular mechanisms in experimental oncology.
Kreuser ED; Wadler S; Thiel E
Recent Results Cancer Res; 1995; 139():371-82. PubMed ID: 7597304
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
Jain N; Lam YM; Pym J; Campling BG
Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
[TBL] [Abstract][Full Text] [Related]
14. Proteasomal inhibition potentiates drugs targeting DNA topoisomerase II.
Lee KC; Bramley RL; Cowell IG; Jackson GH; Austin CA
Biochem Pharmacol; 2016 Mar; 103():29-39. PubMed ID: 26794000
[TBL] [Abstract][Full Text] [Related]
15. Relationship between expression of topoisomerase II isoforms and chemosensitivity in choroidal melanoma.
Satherley K; de Souza L; Neale MH; Alexander RA; Myatt N; Foss AJ; Hungerford JL; Hickson ID; Cree IA
J Pathol; 2000 Oct; 192(2):174-81. PubMed ID: 11004693
[TBL] [Abstract][Full Text] [Related]
16. Topoisomerase II activities in AML blasts and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxines.
Gieseler F; Glasmacher A; Kämpfe D; Wandt H; Nuessler V; Valsamas S; Kunze J; Wilms K
Leukemia; 1996 Jul; 10 Suppl 3():S46-S49. PubMed ID: 8656700
[TBL] [Abstract][Full Text] [Related]
17. Synergistic interaction between histone deacetylase and topoisomerase II inhibitors is mediated through topoisomerase IIbeta.
Marchion DC; Bicaku E; Turner JG; Daud AI; Sullivan DM; Munster PN
Clin Cancer Res; 2005 Dec; 11(23):8467-75. PubMed ID: 16322310
[TBL] [Abstract][Full Text] [Related]
18. Catalytic inhibitors of DNA topoisomerase II.
Andoh T; Ishida R
Biochim Biophys Acta; 1998 Oct; 1400(1-3):155-71. PubMed ID: 9748552
[TBL] [Abstract][Full Text] [Related]
19. Structure-based design, synthesis and biological testing of piperazine-linked bis-epipodophyllotoxin etoposide analogs.
Yadav AA; Chee GL; Wu X; Patel D; Yalowich JC; Hasinoff BB
Bioorg Med Chem; 2015 Jul; 23(13):3542-51. PubMed ID: 25922181
[TBL] [Abstract][Full Text] [Related]
20. DNA topoisomerase II poisons and inhibitors.
Capranico G; Giaccone G; Zunino F; Garattini S; D'Incalci M
Cancer Chemother Biol Response Modif; 1997; 17():114-31. PubMed ID: 9551211
[No Abstract] [Full Text] [Related]
[Next] [New Search]